Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

Jorge E. Cortes, Hanna J. Khoury, Hagop M. Kantarjian, Jeff H. Lipton, Dong Wook Kim, Philippe Schafhausen, Ewa Matczak, Eric Leip, Kay Noonan, Tim H. Brümmendorf, Carlo Gambacorti-Passerini

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint Dive into the research topics of 'Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences